Skip to main content

ImmunityBio, Inc.

IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001326110

In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 2 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding ImmunityBio, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of IBRX: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders2424264+26
Shares124.1M113.8K143.1M+19.1M (+15.4%)
Value$327.9M$300.3K$352.1M+$24.5M (+7.5%)

4 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (49)

Institutions that held ImmunityBio, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to IBRX in Q3 2025
InstitutionSharesValue% of portfolio
Heights Capital Management, Inc6,565,709$16.2M5.13%
Renaissance Technologies LLC1,016,199$2.50M0.00%
Squarepoint Ops LLC1,013,291$2.49M0.01%
Susquehanna Portfolio Strategies, LLC393,587$968.2K0.02%
Quadrature Capital Ltd262,391$642.9K0.01%
Marshall Wace, LLP254,814$626.8K0.00%
ExodusPoint Capital Management, LP162,383$399.5K0.01%
DRW Securities, LLC142,388$349.0K0.02%
Two Sigma Advisers, LP117,656$289.4K0.00%
Sowell Financial Services LLC103,685$255.1K0.01%
Man Group plc101,500$249.7K0.00%
Godsey & Gibb Associates54,100$133.1K0.01%
Schonfeld Strategic Advisors LLC49,458$121.7K0.00%
Legacy Financial Advisors, Inc.45,250$111.3K0.02%
Leavell Investment Management, Inc.35,012$86.1K0.00%
SG Americas Securities, LLC30,306$75.0K0.00%
CIBC Bancorp USA Inc.24,521$60.3K0.00%
Hills Bank & Trust Co24,183$59.5K0.00%
Alpine Global Management, LLC22,753$56.0K0.01%
Balyasny Asset Management LLC17,726$43.6K0.00%
R Squared Ltd17,470$43.0K0.02%
Farringdon Capital, Ltd.16,644$40.9K0.01%
Voleon Capital Management LP16,254$40.0K0.00%
Advus Financial Partners, LLC14,751$36.3K0.01%
Maltin Wealth Management, Inc.13,150$32.3K0.01%
Blackstone Group Inc.11,944$29.4K0.00%
Cerity Partners LLC11,468$28.2K0.00%
Wealthfront Advisers LLC11,249$27.7K0.00%
Swiss Life Asset Management Ltd10,957$27.0K0.00%
Truist Financial Corp10,900$26.8K0.00%
Slow Capital, Inc.10,000$24.6K0.00%
Northwestern Mutual Wealth Management Co8,505$20.9K0.00%
Quantbot Technologies LP6,206$15.3K0.00%
Advisory Services Network, LLC5,106$12.6K0.00%
Bryn Mawr Trust Co5,000$12.3K0.00%
Archer Investment Corp3,514$8.64K0.00%
MCF Advisors LLC2,146$5.28K0.00%
Wiser Advisor Group LLC2,000$4.92K0.01%
Rockefeller Capital Management L.P.1,290$3.17K0.00%
Sittner & Nelson, LLC1,000$2.46K0.00%
Signature Resources Capital Management, LLC1,000$2.46K0.00%
Caitlin John, LLC1,000$2.46K0.00%
Groupe la Francaise1,000$2.19K0.00%
Caitong International Asset Management Co., Ltd727$1.79K0.00%
Harbor Investment Advisory, LLC375$9230.00%
Wealthspire Advisors, LLC224$5520.00%
Root Financial Partners, LLC86$2120.00%
Federation des caisses Desjardins du Quebec42$1030.00%
Cloud Capital Management, LLC9$00.00%

Sold out (23)

Institutions that held ImmunityBio, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Not filed for Q3 2025 yet (4)

Institutions that held ImmunityBio, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IBRX in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Good Life Advisors, LLC57,311$151.3K
CIBC World Markets Corp28,343$74.8K
E Fund Management Co., Ltd.28,108$74.2K
Parkworth Wealth Management, Inc.7$18